InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
| Product | Citation | Year | Journal | Authors | Page |
|---|---|---|---|---|---|
| Human TLR7 Reporter HEK293 Cells (NF-κB) | Protocol for evaluation and validation of TLR8 antagonists in HEK-Blue cells ... | 2022 | STAR Protoc. | Hu Z. et al. | DOI: 10.1016/j.xpro.2021.101061 |
| Pam2CSK4 | Protocol for evaluation and validation of TLR8 antagonists in HEK-Blue cells ... | 2022 | STAR Protoc. | Hu Z. et al. | DOI: 10.1016/j.xpro.2021.101061 |
| FLA-BS (Standard or Ultrapure) | Protocol for evaluation and validation of TLR8 antagonists in HEK-Blue cells ... | 2022 | STAR Protoc. | Hu Z. et al. | DOI: 10.1016/j.xpro.2021.101061 |
| ODN 2006 (ODN 7909) | Protocol for evaluation and validation of TLR8 antagonists in HEK-Blue cells ... | 2022 | STAR Protoc. | Hu Z. et al. | DOI: 10.1016/j.xpro.2021.101061 |
| LPS-B5 (LPS from E. coli 055:B5) | Protocol for evaluation and validation of TLR8 antagonists in HEK-Blue cells ... | 2022 | STAR Protoc. | Hu Z. et al. | DOI: 10.1016/j.xpro.2021.101061 |
| R848 (Resiquimod) | Protocol for evaluation and validation of TLR8 antagonists in HEK-Blue cells ... | 2022 | STAR Protoc. | Hu Z. et al. | DOI: 10.1016/j.xpro.2021.101061 |
| Human TLR4 Reporter HEK293 Cells (NF-κB) | Protocol for evaluation and validation of TLR8 antagonists in HEK-Blue cells ... | 2022 | STAR Protoc. | Hu Z. et al. | DOI: 10.1016/j.xpro.2021.101061 |
| Pam3CSK4 | Protocol for evaluation and validation of TLR8 antagonists in HEK-Blue cells ... | 2022 | STAR Protoc. | Hu Z. et al. | DOI: 10.1016/j.xpro.2021.101061 |
| Poly(I:C) HMW | Protocol for evaluation and validation of TLR8 antagonists in HEK-Blue cells ... | 2022 | STAR Protoc. | Hu Z. et al. | DOI: 10.1016/j.xpro.2021.101061 |
| Human TLR2 Reporter HEK293 Cells (NF-κB) | Protocol for evaluation and validation of TLR8 antagonists in HEK-Blue cells ... | 2022 | STAR Protoc. | Hu Z. et al. | DOI: 10.1016/j.xpro.2021.101061 |
| Human TLR9 Reporter HEK293 Cells (NF-κB) | Protocol for evaluation and validation of TLR8 antagonists in HEK-Blue cells ... | 2022 | STAR Protoc. | Hu Z. et al. | DOI: 10.1016/j.xpro.2021.101061 |
| HEK-Blue™ Null1 Cells | Protocol for evaluation and validation of TLR8 antagonists in HEK-Blue cells ... | 2022 | STAR Protoc. | Hu Z. et al. | DOI: 10.1016/j.xpro.2021.101061 |
| Normocin™ - Antimicrobial Reagent | Protocol for evaluation and validation of TLR8 antagonists in HEK-Blue cells ... | 2022 | STAR Protoc. | Hu Z. et al. | DOI: 10.1016/j.xpro.2021.101061 |
| Blasticidin | Protocol for evaluation and validation of TLR8 antagonists in HEK-Blue cells ... | 2022 | STAR Protoc. | Hu Z. et al. | DOI: 10.1016/j.xpro.2021.101061 |
| pFUSE-Lucia-CHIg-hG1 | Human monoclonal antibodies against Staphylococcus aureus surface antigens re... | 2022 | Elife | de Vor L. et al. | DOI: 10.7554/eLife.67301 |
| pFUSE-CHIg-hG3 | Human monoclonal antibodies against Staphylococcus aureus surface antigens re... | 2022 | Elife | de Vor L. et al. | DOI: 10.7554/eLife.67301 |
| pFUSE2-CLIg-hK | Human monoclonal antibodies against Staphylococcus aureus surface antigens re... | 2022 | Elife | de Vor L. et al. | DOI: 10.7554/eLife.67301 |
| Zeocin® | Non-selective TRPC channel inhibition and suppression of aminoglycoside-induc... | 2022 | J Biol Chem | Baradaran-Heravi A. et al. | DOI: 10.1016/j.jbc.2021.101546 |
| FLA-ST (Standard or Ultrapure) | Salmonid MyD88 is a key adapter protein that activates innate effector mechan... | 2022 | Fish Shellfish Immunol | Muñoz-Flores C. et al. | DOI: 10.1016/j.fsi.2021.12.030 |
| CFA | Inactivated whole hepatitis C virus vaccine employing a licensed adjuvant eli... | 2022 | J Hepatol | Finne Pihl A. et al. | DOI: 10.1016/j.jhep.2021.12.026 |